Newsroom

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Hauptsitz in Tokio; President und Representative Director: Toshiaki Nagasato) gab heute bekannt, dass die Ergebnisse der Integral-1-Studie, einer von zwei globalen klinischen Phase-III-Studien zur Bewertung der Wirksamkeit und Sicherheit des neuartigen β-Lactamase-Hemmers Nacubactam (Tntwicklungscode: OP0595), in The Lancet veröffentlicht wurden. Der Artikel lautet „Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared...

LONDON--(BUSINESS WIRE)--Endava, the technology-driven business transformation group whose AI-native approach combines cutting-edge technology with deep industry expertise today announced a strategic partnership with Tyl by NatWest, NatWest Group’s merchant-payments arm, to accelerate the evolution of its offering. The partnership is focused on enabling Tyl’s customers to access a modern, fully integrated payments acceptance experience. By combining Endava's global operations and its AI-native...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 14.05.2026 MMAR.LN IE0002PPCMH6   50,002.00 USD   1,326,609.29   26.531  ...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (oficinas centrales: Tokio; presidente y director representante: Toshiaki Nagasato) anunció hoy que los resultados del estudio Integral-1, uno de dos ensayos clínicos de fase 3 globales que evalúan la eficacia y la seguridad de nacubactam (código de desarrollo: OP0595), su nuevo inhibidor de β-lactamasa, fueron publicados en The Lancet. El artículo se titula “Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with im...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 14.05.2026 RCTR.LN IE000J5PESP7  150,002.00 USD   2,974,304.77   19.828  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 14.05.2026 EDVY.LN IE000CPG9HG3 50,002.00 EUR 1,058,467.18 21.169  ...

HAMILTON, Ontario--(BUSINESS WIRE)--Porter Airlines lance deux nouveaux itinéraires pour élargir son réseau de Hamilton vers d’autres destinations au Canada. Le service sans escale entre Hamilton (YHM) et Winnipeg (YWG) a débuté hier, offrant jusqu’à six aller-retour par semaine. De plus, des vols de Hamilton à St. John’s (YYT) débutent aujourd’hui, et un service quotidien est prévu dès la fin juin. Voici l’horaire des vols initiaux : Itinéraire Départ Arrivée Winnipeg à Hamilton 18 h 55 22 h 0...

HAMILTON, Ontario--(BUSINESS WIRE)--Porter Airlines is launching two new routes, expanding its Hamilton network across Canada. Nonstop service between Hamilton (YHM) and Winnipeg (YWG) began yesterday, operating up to six roundtrips weekly. Hamilton - St. John’s (YYT) takes off today, with daily service by late June. The initial flight schedules are as follows: Route Departure Arrival Winnipeg to Hamilton 6:55 p.m. 10:09 p.m. Hamilton to Winnipeg 7:00 a.m. 8:25 a.m. St. John’s to Hamilton 2:45...

WINNIPEG, Manitoba--(BUSINESS WIRE)--Exchange Income Corporation Announces May 2026 Dividend...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that it will report its first quarter 2026 financial results on Monday, May 18, 2026. In connection with the earnings release, Gossamer’s management team will host a live conf...